Medical Oncology

• 

  Subject Areas on Research

  • "Who Does What?" Ensuring High-Quality and Coordinated Palliative Care With Our Oncology Colleagues. 
  • "You have to be sure that the patient has the full picture": Adaptation of the Best Case/Worst Case communication tool for geriatric oncology. 
  • 1995 AUR Gold Medal Awards. David Gordon Bragg, MD. 
  • 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel. 
  • A Call to Action: Ethics Committee Roundtable Recommendations for Addressing Burnout and Moral Distress in Oncology. 
  • A Grant-Based Experiment to Train Clinical Investigators: The AACR/ASCO Methods in Clinical Cancer Research Workshop. 
  • A Multidisciplinary Consensus Recommendation on a Synoptic Radiation Treatment Summary: A Commission on Cancer Workgroup Report. 
  • A New Frontier for Palliative Care: The Need to Train Palliative-Oncology Subspecialists. 
  • A Society for Pediatric Urology Workforce Survey on the Current Perceptions of Oncology Care by Pediatric Urologists: A Report from the Pediatric Urologic Oncology Working Group of the Society for Pediatric Urology. 
  • A Standardized Education Checklist for Parents of Children Newly Diagnosed With Cancer: A Report From the Children's Oncology Group. 
  • A Systematic Literature Review of Animal-Assisted Interventions in Oncology (Part I): Methods and Results. 
  • A Systematic Literature Review of Animal-Assisted Interventions in Oncology (Part II): Theoretical Mechanisms and Frameworks. 
  • A Web-based communication aid for patients with cancer: the CONNECT Study. 
  • A broad perspective on evaluating bias in the neuro-oncology workplace. 
  • A message from the Editor-in-Chief. 
  • A model for the shared care of elderly patients with cancer. 
  • A novel simulator model and standardized assessment tools for fine needle aspiration cytology training. 
  • A path to translation: How 3D patient tumor avatars enable next generation precision oncology. 
  • A sociology of precision-in-practice: The affective and temporal complexities of everyday clinical care. 
  • A urologic oncology roundtable discussion: issues to consider in choosing treatment for metastatic castration-resistant prostate cancer. 
  • ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. 
  • ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. 
  • Achieving oncology mental health providers' usage of an empirically supported treatment: Lessons learned. 
  • Action for Increasing Diversity, Market Access, and Capacity in Oncology Registration Trials-Is Africa the Answer? Report From a Satellite Session of the Accelerating Anti-Cancer Agent Development and Validation Workshop. 
  • Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. 
  • Acute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology. 
  • Adapting to a Pandemic - Conducting Oncology Trials during the SARS-CoV-2 Pandemic. 
  • Addressing the dichotomy between individual and societal approaches to personalised medicine in oncology. 
  • Advanced Analytics as an Accelerator for Palliative Care and Oncology Integration. 
  • Allogeneic hematopoietic SCT for alpha-mannosidosis: an analysis of 17 patients. 
  • American College of Surgeons Oncology Group and the community surgeon. 
  • American Society of Clinical Oncology 2013 top five list in oncology. 
  • American Society of Clinical Oncology Clinical Practice Guidelines: formal systematic review-based consensus methodology. 
  • American Society of Clinical Oncology clinical practice guidelines: opportunities and challenges. 
  • American Society of Clinical Oncology guidance statement: the cost of cancer care. 
  • American Society of Clinical Oncology statement: achieving high-quality cancer survivorship care. 
  • An assessment of end-of-life-care training: should we consider a cross-fellowship, competency-based simulated program? 
  • An integrated approach to the prediction of chemotherapeutic response in patients with breast cancer. 
  • Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. 
  • Anti-cancer therapy and clinical trial considerations for gynecologic oncology patients during the COVID-19 pandemic crisis. 
  • Application of a new multinomial phase II stopping rule using response and early progression. 
  • Applying the Society of Radiologists in Ultrasound recommendations for fine-needle aspiration of thyroid nodules: effect on workup and malignancy detection. 
  • Arti Hurria and the progress in integrating the geriatric assessment into oncology: Young International Society of Geriatric Oncology review paper. 
  • Arti Hurria, M.D.: A tribute to her shining legacy in the Alliance for Clinical Trials in Oncology. 
  • Assessing the Impact of a Novel Integrated Palliative Care and Medical Oncology Inpatient Service on Health Care Utilization before Hospice Enrollment. 
  • Assessment of quality of life in outpatients with advanced cancer: the accuracy of clinician estimations and the relevance of spiritual well-being--a Hoosier Oncology Group Study. 
  • Association of Diet Quality With Survival Among People With Metastatic Colorectal Cancer in the Cancer and Leukemia B and Southwest Oncology Group 80405 Trial. 
  • Associations of Early Completion of Advance Directives With Key End-of-Life Quality Measures: Analysis of an ASCO Quality Oncology Practice Initiative Patient Cohort. 
  • Attitudes regarding the use of hematopoietic colony-stimulating factors and maintenance of relative dose intensity among gynecologic oncologists. 
  • Better Palliative Care for All: Improving the Lived Experience With Cancer. 
  • Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. 
  • Bladder cancer. Clinical guidelines in oncology. 
  • Breakout IV. Health professional concerns in the practice setting. 
  • Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. 
  • Breast cancer and aging: Standing on the shoulders of a giant. 
  • Bridging the gap between financial distress and available resources for patients with cancer: a qualitative study. 
  • Cancer Moonshot Data and Technology Team: Enabling a National Learning Healthcare System for Cancer to Unleash the Power of Data. 
  • Cancer Moonshot Immuno-Oncology Translational Network (IOTN): accelerating the clinical translation of basic discoveries for improving immunotherapy and immunoprevention of cancer. 
  • Cancer and leukemia group B gastrointestinal cancer committee. 
  • Cancer immunotherapy innovator James Allison receives the 2015 Lasker~DeBakey Clinical Medical Research Award. 
  • Cancer therapy costs influence treatment: a national survey of oncologists. 
  • Cancer- and chemotherapy-induced anemia. 
  • Cancer-Associated Venous Thromboembolic Disease, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. 
  • Cardio-Oncology Education and Training: JACC Council Perspectives. 
  • Cardio-Oncology Rehabilitation to Manage Cardiovascular Outcomes in Cancer Patients and Survivors: A Scientific Statement From the American Heart Association. 
  • Cardio-Oncology Training: A Proposal From the International Cardioncology Society and Canadian Cardiac Oncology Network for a New Multidisciplinary Specialty. 
  • Cardio-Oncology in the Era of the COVID-19 Pandemic and Beyond. 
  • Cardiorespiratory exercise testing in clinical oncology research: systematic review and practice recommendations. 
  • Cardiovascular Health of Patients With Cancer and Cancer Survivors: A Roadmap to the Next Level. 
  • Care coordination for complex cancer survivors in an integrated safety-net system: a study protocol. 
  • Case for Dual Training in Medical Oncology and Palliative Care. 
  • Case study: Transforming cancer care at a community oncology practice. 
  • Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. 
  • Challenges and opportunities for in vivo imaging in oncology. 
  • Challenges associated with the integration of immuno-oncology agents in clinical practice. 
  • Challenges to accrual predictions to phase III cancer clinical trials: a survey of study chairs and lead statisticians of 248 NCI-sponsored trials. 
  • Change in Eyelid Carcinoma T Category With Use of the 8th Versus 7th Edition of the American Joint Committee on Cancer: Cancer Staging Manual. 
  • Characteristics and treatment options of elderly Chinese patients with cancer as determined by Comprehensive Geriatric Assessment (CGA). 
  • Chemotherapy administration for ovarian cancer by gynecologic oncologists and medical oncologists. 
  • Chemotherapy use and patient treatment preferences in advanced colorectal cancer: a prospective cohort study. 
  • Child and adolescent self-report symptom measurement in pediatric oncology research: a systematic literature review. 
  • Childhood cancer survivorship educational resources in North American pediatric hematology/oncology fellowship training programs: a survey study. 
  • Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology. 
  • Chronic Myeloid Leukemia, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology. 
  • Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. 
  • Clinical Cancer Advances 2020: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology. 
  • Clinical Cancer Advances 2021: ASCO's Report on Progress Against Cancer. 
  • Clinical Trials with Biologic Primary Endpoints in Immuno-oncology: Concepts and Usage. 
  • Clinical Utility and User Perceptions of a Digital System for Electronic Patient-Reported Symptom Monitoring During Routine Cancer Care: Findings From the PRO-TECT Trial. 
  • Clinical cancer advances 2012: annual report on progress against cancer from the american society of clinical oncology. 
  • Clinical experience of patients referred to a multidisciplinary cardio-oncology clinic: an observational cohort study. 
  • Clinician Perspectives on Managing Chronic Pain After Curative-Intent Cancer Treatment. 
  • Collaboration between breast and reconstructive surgery in optimizing outcomes for women with breast cancer. 
  • Colon cancer. 
  • Comorbidity in older adults with cancer. 
  • Comparative Effectiveness of Tumor Response Assessment Methods: Standard of Care Versus Computer-Assisted Response Evaluation. 
  • Comparative effectiveness research in oncology: an overview. 
  • Comparative effectiveness research in oncology: the need for clarity, transparency and vision. 
  • Comparative effectiveness research: moving medical oncology forward. 
  • Comparing oncologist, nurse, and physician assistant attitudes toward discussions of negative emotions with patients. 
  • Comparison of Quality Oncology Practice Initiative (QOPI) Measure Adherence Between Oncology Fellows, Advanced Practice Providers, and Attending Physicians. 
  • Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: implications for residual disease detection: a report from the children's oncology group. 
  • Comprehensive handbook for developing a bladder cancer cystectomy database. 
  • Comprehensive review of implications of COVID-19 on clinical outcomes of cancer patients and management of solid tumors during the pandemic. 
  • Condition-specific or generic preference-based measures in oncology? A comparison of the EORTC-8D and the EQ-5D-3L. 
  • Congruence of patient- and clinician-reported toxicity in women receiving chemotherapy for early breast cancer. 
  • Consensus statement on depression, anxiety, and oncology. 
  • Continental Divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs. 
  • Continued Supervision for the Common Pediatric Subspecialty Entrustable Professional Activities May Be Needed Following Fellowship Graduation. 
  • Contributions from surgeons to clinical trials and research on the management of soft tissue sarcoma. 
  • Cost effectiveness of intraperitoneal compared with intravenous chemotherapy for women with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. 
  • Cost implications of the SSO-ASTRO consensus guideline on margins for breast-conserving surgery with whole breast irradiation in stage I and II invasive breast cancer. 
  • Cost of cancer care: issues and implications. 
  • Cost-related health literacy: a key component of high-quality cancer care. 
  • Counting the costs of cancer care. 
  • Creating a Blueprint of Well-Being in Oncology: An Approach for Addressing Burnout From ASCO's Clinician Well-Being Taskforce. 
  • Creating computable algorithms for symptom management in an outpatient thoracic oncology setting. 
  • Critical review of the addition of tumor treating fields (TTFields) to the existing standard of care for newly diagnosed glioblastoma patients. 
  • Current Practices for Screening and Management of Financial Distress at NCCN Member Institutions. 
  • Current Trends in the Management of Ductal Carcinoma In Situ. 
  • Current drug development and trial designs in neuro-oncology: report from the first American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials Conference. 
  • Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. 
  • Data standards in pediatric oncology: Past, present, and future. 
  • Decision making and quality of life in the treatment of cancer: a review. 
  • Decision making in pediatric oncology: who should take the lead? The decisional priority in pediatric oncology model. 
  • Defining Value of Cancer Therapeutics-A Health System Perspective. 
  • Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee. 
  • Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement. 
  • Defining the chance of cure after resection for hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guidelines: A multi-institutional analysis of 1,010 patients. 
  • Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations. 
  • Development of a telemedicine model for emerging countries: a case study on pediatric oncology in Brazil. 
  • Discussing Health Care Expenses in the Oncology Clinic: Analysis of Cost Conversations in Outpatient Encounters. 
  • Diversity Among Surgical Faculty, Residents, and Oncology Fellows from 2011/2012 to 2019/2020. 
  • Do patient attributes predict oncologist empathic responses and patient perceptions of empathy? 
  • Do what you love. Love what you do. Dr. Arti Hurria's trailblazing transdisciplinary legacy. 
  • Do you mind if I record?: Perceptions and practice regarding patient requests to record clinic visits in oncology. 
  • Documenting the activities of the oncology clinical nurse specialist. 
  • Does integration of Magee equations into routine clinical practice affect whether oncologists order the Oncotype DX test? A prospective randomized trial. 
  • Early integration of palliative care into the care of patients with cancer. 
  • Editor's note: Say "Yes!" to NO. 
  • Educating Families of Children Newly Diagnosed With Cancer. 
  • Effect of patient and patient-oncologist relationship characteristics on communication about health-related quality of life. 
  • Electronic Geriatric Assessment: Is It Feasible in a Multi-Institutional Study That Included a Notable Proportion of Older African American Patients? (Alliance A171603). 
  • Electronic Health Records (EHRs) in the oncology clinic: how clinician interaction with EHRs can improve communication with the patient. 
  • Electronic symptom monitoring in pediatric patients hospitalized for chemotherapy. 
  • Engaging Multidisciplinary Stakeholders to Drive Shared Decision-Making in Oncology. 
  • Enhancing communication between oncologists and patients with a computer-based training program: a randomized trial. 
  • Enrollment of patients with lung and colorectal cancers onto clinical trials. 
  • Ensuring comprehensive assessment of urinary problems in prostate cancer through patient-physician concordance. 
  • Epilogue: the peril and the promise of comparative effectiveness research in oncology. 
  • Erythropoiesis-stimulating agent use in cancer: preclinical and clinical perspectives. 
  • Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group. 
  • Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. 
  • Esophageal cancer. Clinical practice guidelines in oncology. 
  • Establishing a framework for improving the quality of clinical and translational research. 
  • Evaluating physician performance in oncology: moneyball becomes impactball. 
  • Evaluation of a Virtual Learning Collaborative to Integrate Palliative Care Into Routine Oncology Practice. 
  • Evidence-based medical oncology and interventional radiology paradigms for liver-dominant colorectal cancer metastases. 
  • Evidence-based oncology in cancer treatment reviews. 
  • Evolution of Geriatric Assessment in Oncology. 
  • Evolution of the Quality Oncology Practice Initiative supportive care quality measures portfolio and conformance at a Veterans Affairs medical center. 
  • Examining guidelines and new evidence in oncology nutrition: a position paper on gaps and opportunities in multimodal approaches to improve patient care. 
  • Experts on their own experiences: the rise of patient-reported outcomes in oncology drug trials. 
  • Factors associated with African Americans' enrollment in a national cancer genetics registry. 
  • Features associated with successful recruitment of diverse patients onto cancer clinical trials: report from the American College of Surgeons Oncology Group. 
  • Frequency, nature, effects, and correlates of conflicts of interest in published clinical cancer research. 
  • From Assessment to Implementation and Beyond in Cancer and Aging Research. 
  • From Protocols to Publications: A Study in Selective Reporting of Outcomes in Randomized Trials in Oncology. 
  • Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. 
  • Gastric cancer. Clinical practice guidelines in oncology. 
  • Gefitinib (Iressa, ZD1839) and tyrosine kinase inhibitors: the wave of the future in cancer therapy. 
  • Gene therapy in urologic oncology. 
  • Generalists and oncologists show similar care practices and outcomes for hospitalized late-stage cancer patients. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks for Treatment. 
  • Genetic counseling and testing for breast-ovarian cancer susceptibility: what do women want? 
  • Geriatric assessment for oncologists: rationale and future directions. 
  • Geriatric assessment with management in cancer care: Current evidence and potential mechanisms for future research. 
  • Geriatric oncology health services research: Cancer and Aging Research Group infrastructure core. 
  • Geriatric oncology. 
  • Gestational Trophoblastic Neoplasia, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. 
  • Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium. 
  • Guidelines of the National Comprehensive Cancer Network on the use of myeloid growth factors with cancer chemotherapy: a review of the evidence. 
  • Harnessing the Synergy Between Improvement Science and Implementation Science in Cancer: A Call to Action. 
  • Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. 
  • Head and neck cancers. 
  • Health Services Research: Not just retrospective chart reviews. 
  • Hematology/Oncology Fellowship Programs' Participation in the Quality Oncology Practice Initiative. 
  • Highlights in advanced prostate cancer from the 2022 American Society of Clinical Oncology Genitourinary Cancers Symposium: commentary. 
  • Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. 
  • Hodgkin lymphoma, version 2.2012 featured updates to the NCCN guidelines. 
  • How long and how well: oncologists' attitudes toward the relative value of life-prolonging v. quality of life-enhancing treatments. 
  • How oncologists and their patients with advanced cancer communicate about health-related quality of life. 
  • Human Flourishing in Adolescents with Cancer: Experiences of Pediatric Oncology Health Care Professionals. 
  • Improvements in Patient and Health System Outcomes Using an Integrated Oncology and Palliative Medicine Approach on a Solid Tumor Inpatient Service. 
  • Improving Cancer Care for People Living With HIV: A Qualitative Study of Provider Knowledge, Attitudes, and Practice. 
  • Improving Oncology Quality Measurement in Accountable Care: Filling Gaps with Cross-Cutting Measures. 
  • Improving evidence developed from population-level experience with targeted agents. 
  • Improving health care efficiency and quality using tablet personal computers to collect research-quality, patient-reported data. 
  • Improving the Evidence Base for Treating Older Adults With Cancer: American Society of Clinical Oncology Statement. 
  • Improving the management of chemotherapy-induced neutropenia. 
  • Improving the methodologic and ethical validity of best supportive care studies in oncology: lessons from a systematic review. 
  • Improving the quality of survivorship for older adults with cancer. 
  • In a survey, marked inconsistency in how oncologists judged value of high-cost cancer drugs in relation to gains in survival. 
  • Incorporating Information From Proxies for Patient-Centered Outcomes in Adult and Pediatric Oncology Settings. 
  • Incorporating palliative radiotherapy education into hospice and palliative medicine fellowship training: a feasibility study. 
  • Increasing Racial and Ethnic Diversity in Cancer Clinical Trials: An American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research Statement. 
  • Independent data monitoring committees: an update and overview. 
  • Innovations in urology from military medicine. 
  • Integrated Palliative and Oncology Care for Patients With Acute Myeloid Leukemia-Moving From Evidence to Practice-Reply. 
  • Integrating machine learning and physician knowledge to improve the accuracy of breast biopsy. 
  • Integration of Electronic Patient-Reported Outcomes Into Routine Cancer Care: An Analysis of Factors Affecting Data Completeness. 
  • Integration of Palliative Care into Acute Myeloid Leukemia Care. 
  • International Perspective on the Pursuit of Quality in Cancer Care: Global Application of QOPI and QOPI Certification. 
  • International Society for Quality of Life Research commentary on the draft European Medicines Agency reflection paper on the use of patient-reported outcome (PRO) measures in oncology studies. 
  • Interobserver agreement on what constitutes visceral pleural invasion by non-small cell lung carcinoma: an internet-based assessment of international current practices. 
  • Introducing new strategies in.. 
  • Introduction. Neutropenia risk models in oncology. 
  • Introduction. Update on adult neuro-oncology. 
  • Kidney cancer. Clinical practice guidelines in oncology. 
  • Knowledge of indications and utilization of EUS: a survey of oncologists in the United States. 
  • Leveraging external data in the design and analysis of clinical trials in neuro-oncology. 
  • Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline. 
  • Making the Right Thing Easier to Do: Standardized Integration of Oncology and Palliative Care. 
  • Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology. 
  • Management of Locoregional Rectal Cancer. 
  • Management of Male Breast Cancer: ASCO Guideline. 
  • Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations. 
  • Management of glioma in Victoria (1998-2000): retrospective cohort study. 
  • Mapping child and adolescent self-reported symptom data to clinician-reported adverse event grading to improve pediatric oncology care and research. 
  • Measuring cause-and-effect relationships without randomized clinical trials: Quasi-experimental methods for gynecologic oncology research. 
  • Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology. 
  • Metabolomics in cancer research and emerging applications in clinical oncology. 
  • Metastatic Hormone-Sensitive Prostate Cancer: A Review of the Current Treatment Landscape. 
  • Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines. 
  • Mind the gap: Gendered publication trends in oncology. 
  • Models for delivering survivorship care. 
  • Models of cancer survivorship health care: moving forward. 
  • Modifying Practices in GI Oncology in the Face of COVID-19: Recommendations From Expert Oncologists on Minimizing Patient Risk. 
  • Molecular imaging in oncology. 
  • Molecular-Guided Off-Label Targeted Therapy in a Large-Scale Precision Oncology Program. 
  • Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology. 
  • Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology. 
  • Multiple authorship in two English-language journals in radiation oncology. 
  • Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. 
  • Myeloid Growth Factors, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. 
  • Myeloid growth factors clinical practice guidelines in oncology. 
  • Myeloproliferative Neoplasms, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. 
  • NCCN Clinical Practice Guidelines Occult primary. 
  • NCCN Guidelines Insights: B-Cell Lymphomas, Version 3.2019. 
  • NCCN Guidelines Insights: Bladder Cancer, Version 5.2018. 
  • NCCN Guidelines Insights: Bone Cancer, Version 2.2017. 
  • NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018. 
  • NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019. 
  • NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018. 
  • NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 5.2018. 
  • NCCN Guidelines Insights: Older Adult Oncology, Version 2.2016. 
  • NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018. 
  • NCCN Guidelines Insights: Uveal Melanoma, Version 1.2019. 
  • NCCN Guidelines® Insights: Older Adult Oncology, Version 1.2021. 
  • NCCN Guidelines® Insights: Palliative Care, Version 2.2021. 
  • NCCN clinical practice guidelines in oncology: prostate cancer early detection. 
  • NCCN clinical practice guidelines in oncology: prostate cancer. 
  • Nanotechnology and tumor imaging: seizing an opportunity. 
  • National Comprehensive Cancer Network Guidelines: Who Makes Them? What Are They? Why Are They Important? 
  • National survey of US oncologists' knowledge, attitudes, and practice patterns regarding herb and supplement use by patients with cancer. 
  • Negative emotions in cancer care: do oncologists' responses depend on severity and type of emotion? 
  • Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. 
  • New NCCN Guidelines for Uveal Melanoma and Treatment of Recurrent or Progressive Distant Metastatic Melanoma. 
  • Next Step for Global Adolescent and Young Adult Oncology: A Core Patient-Centered Outcome Set. 
  • Next generation sequencing and tumor mutation profiling: are we ready for routine use in the oncology clinic? 
  • Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. 
  • Non-small cell lung cancer clinical practice guidelines in oncology. 
  • Non-small cell lung cancer. 
  • Nurse and physician perspectives on patients with cancer having online access to their laboratory results. 
  • Older adult participation in cancer clinical trials: A systematic review of barriers and interventions. 
  • Onco-hypertension: An Emerging Specialty. 
  • Oncologist communication about emotion during visits with patients with advanced cancer. 
  • Oncologist patient-centered communication with patients with advanced cancer: exploring whether race or socioeconomic status matter. 
  • Oncology Care Delivery in the COVID-19 Pandemic: An Opportunity to Study Innovations and Outcomes. 
  • Oncology Navigation Standards of Professional Practice. 
  • Oncology and Palliative Care Integration: Cocreating Quality and Value in the Era of Health Care Reform. 
  • Oncology payment reform to achieve real health care reform. 
  • One Voice Is Good, But More Is Better: Symptom and Toxicity Reporting in Pediatric Oncology. 
  • Online exclusive: functional integration of nursing research into a pediatric oncology cooperative group: finding common ground. 
  • Optimal cancer care across the spectrum of life and disease. 
  • Oral Chemotherapy Metric Performance in Quality Oncology Practice Initiative Practices: Updated Trends and Analysis. 
  • Organizational and physician factors associated with patient enrollment in cancer clinical trials. 
  • Overcoming specialty bias: another important reason for multidisciplinary management of soft tissue sarcoma. 
  • PROMISE: a real-world clinical-genomic database to address knowledge gaps in prostate cancer. 
  • Palliative Care Has Come of Age. 
  • Palliative care and hematologic malignancies: old dog, new tricks? 
  • Palliative care. 
  • Palliative care. Clinical practice guidelines in oncology. 
  • Pathology: Hub and Integrator of Modern, Multidisciplinary [Precision] Oncology. 
  • Patient experience and attitudes toward addressing the cost of breast cancer care. 
  • Patient-Reported Outcomes in Oncology Clinical Trials: Stakeholder Perspectives from the Accelerating Anticancer Agent Development and Validation Workshop 2019. 
  • Patient-reported outcome monitoring in a routine paediatric oncology setting: challenges and opportunities. 
  • Patient-reported quality of supportive care among patients with colorectal cancer in the Veterans Affairs Health Care System. 
  • Patient/Family Education for Newly Diagnosed Pediatric Oncology Patients. 
  • Patients' understanding of oncology clinical endpoints: A literature review. 
  • Pediatric Acute Lymphoblastic Leukemia, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. 
  • Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. 
  • Pediatric Education Discharge Support Strategies for Newly Diagnosed Children With Cancer. 
  • Pediatric Hodgkin Lymphoma, Version 3.2021. 
  • Pediatric oncology nursing. 
  • Perceived misinterpretation rates in oncologic 18F-FDG PET/CT studies: a survey of referring physicians. 
  • Perceptions of palliative care among hematologic malignancy specialists: a mixed-methods study. 
  • Peripheral T-cell lymphoma, NOS, and anaplastic large cell lymphoma. 
  • Personalized Medicine in Genitourinary Oncology Is Happening Now. 
  • Personalized medicine and cancer supportive care: appropriate use of colony-stimulating factor support of chemotherapy. 
  • Pharmacogenetic testing in the face of unclear clinical efficacy: lessons from cytochrome P450 2D6 for tamoxifen. 
  • Phase 2 pilot study of Pathfinders: a psychosocial intervention for cancer patients. 
  • Phase II cancer clinical trials for biomarker-guided treatments. 
  • Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study. 
  • Physical strain and urgent need for ergonomic training among gynecologic oncologists who perform minimally invasive surgery. 
  • Physician Experience and Attitudes Toward Addressing the Cost of Cancer Care. 
  • Physicians' legal defensiveness and knowledge of medical law: comparing Denmark and the USA. 
  • Post-radical prostatectomy management options for positive surgical margins: argument for observation. 
  • Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update. 
  • Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update. 
  • Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology. 
  • Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement. 
  • Pre-Treatment Staging Imaging in Rectal Cancer: Results From the Quality Oncology Practice Initiative. 
  • Precision Medicine for Critical Illness and Injury. 
  • Precision Medicine for Heart Failure: Lessons From Oncology. 
  • Precision medicine in addiction research: where has the time gone? 
  • Precision oncology: A primer for pediatric surgeons from the APSA cancer committee. 
  • Predictors of chemotherapy-induced neutropenia and its complications: results from a prospective nationwide registry. 
  • Preoperative or postoperative radiotherapy versus surgery alone for retroperitoneal sarcoma: a case-control, propensity score-matched analysis of a nationwide clinical oncology database. 
  • Prescribing an App? Oncology Providers' Views on Mobile Health Apps for Cancer Care. 
  • Processes to activate phase III clinical trials in a Cooperative Oncology Group: the Case of Cancer and Leukemia Group B. 
  • Profiles of Symptom Suffering and Functioning in Children and Adolescents Receiving Chemotherapy. 
  • Prognostic Communication Between Oncologists and Parents of Children With Advanced Cancer. 
  • Prognostic Value of the Staging System for Eyelid Tumors in the 7th Edition of the American Joint Committee on Cancer Staging Manual. 
  • Prognostication and Communication in Oncology. 
  • Progress in breast cancer-can we do better? 
  • Projecting the need for gynecologic oncologists for the next 40 years. 
  • Promoting Accrual of Older Patients with Cancer to Clinical Trials: An Alliance for Clinical Trials in Oncology Member Survey (A171602). 
  • Proposed Criteria for Systematic Evaluation of Qualitative Oncology Research. 
  • Prostate cancer early detection. Clinical practice guidelines in oncology. 
  • Prostate cancer surgical practice guidelines. Society of Surgical Oncology practice guidelines. 
  • Provider Practice Competition and Adoption of Medicare's Oncology Care Model. 
  • Purchasing oncology services. Kerr L. White Institute/American Cancer Society Task Force on Purchasing Oncology Services. 
  • Radiation Therapy Oncology Group. Research Plan 2002-2006. Cancer Prevention and Control Committee. 
  • Radiologic and nuclear events: contingency planning for hematologists/oncologists. 
  • Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. 
  • Rationale and emerging strategies for immune checkpoint blockade in soft tissue sarcoma. 
  • Rationing in urologic oncology: lessons from sipuleucel-T for advanced prostate cancer. 
  • ReCAP: Feasibility and Effectiveness of a Pilot Program to Facilitate Quality Improvement Learning in Oncology: Experience of the American Society of Clinical Oncology Quality Training Program. 
  • Real-World Approaches to Quality Improvement in Oncology. 
  • Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology. 
  • Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update. 
  • Recommendations on the use of 18F-FDG PET in oncology. 
  • Recommendations on the use of item libraries for patient-reported outcome measurement in oncology trials: findings from an international, multidisciplinary working group. 
  • Recommended scoring approach for the pediatric patient-reported outcomes version of the Common Terminology Criteria for Adverse Events. 
  • Recruiting participants to cancer prevention clinical trials: lessons from successful community oncology networks. 
  • Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. 
  • Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. 
  • Redesigning Oncology Care Delivery: Early Wins, Lessons Learned, and a Roadmap. 
  • Reflections from a chair: Leadership of a clinical department at an academic medical center. 
  • Reflections on and future of hematologic malignancies research in the Veterans Health Administration. 
  • Relationship Between Participation in ASCO's Quality Oncology Practice Initiative Program and American Board of Internal Medicine's Maintenance of Certification Program. 
  • Reply to 'Assembling the brain trust: the multidisciplinary imperative in neuro-oncology'. 
  • Reply to Comment on "Use of Patient Registries and Administrative Datasets for the Study of Pediatric Cancer". 
  • Reply to S. Boutayeb et al. 
  • Response: Proposing and Meeting the Need for Interdisciplinary Cardio-Oncology Subspecialty Training by Sherry-Ann Brown, MD, PhD and Nicole Sandhu, MD, PhD. 
  • Review and update of uncommon primary pleural tumors: a practical approach to diagnosis. 
  • Role of Imaging in the Era of Precision Medicine. 
  • Scientific innovation--pathway to progress in women's cancer. 
  • Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations†. 
  • Seeing into cells. The promise of in vivo molecular imaging in oncology. 
  • Senior adult oncology clinical practice guidelines in oncology. 
  • Senior adult oncology. 
  • Shared Decision-making in Acute Myeloid Leukemia. 
  • Shared care of adult survivors of childhood cancers. 
  • Simulated Costs of the ASCO Patient-Centered Oncology Payment Model in Medicare Beneficiaries With Newly Diagnosed Advanced Ovarian Cancer. 
  • Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. 
  • Small cell lung cancer clinical practice guidelines in oncology. 
  • Smoking Cessation, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. 
  • Smoking Cessation, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. 
  • Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. 
  • Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. 
  • Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. 
  • Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. 
  • Special techniques in diagnostic electron microscopy. 
  • Standards for palliative care delivery in oncology settings. 
  • Statistical issues in translational cancer research. 
  • Studying communication in oncologist-patient encounters: the SCOPE Trial. 
  • Survivorship care plans in research and practice. 
  • Survivorship care plans: is there buy-in from community oncology providers? 
  • Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. 
  • Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. 
  • Sustainability and performance of the National Cancer Institute's Community Clinical Oncology Program. 
  • System-Level Health-Care Integration and the Costs of Cancer Care Across the Disease Continuum. 
  • Systemic Mastocytosis, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. 
  • Systemic Therapy Decision Making in Advanced Cancer: A Qualitative Analysis of Patient-Oncologist Encounters. 
  • Testicular cancer. Clinical practice guidelines in oncology. 
  • The "value" of value in gynecologic oncology practice in the United States: Society of Gynecologic Oncology evidence-based review and recommendations. 
  • The Future of Childhood Cancer Survivorship: Challenges and Opportunities for Continued Progress. 
  • The International Association Study Lung Cancer (IASLC) Strategic Screening Advisory Committee (SSAC) response to the USPSTF recommendations. 
  • The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations. 
  • The National Physicians Cooperative: transforming fertility management in the cancer setting and beyond. 
  • The Oncology Geriatric Education Retreat: commentary and conclusions. 
  • The State of Melanoma: Emergent Challenges and Opportunities. 
  • The beginning of a new journal. 
  • The cancer translational research informatics platform. 
  • The ethics of health information technology in oncology: emerging isssues from both local and global perspectives. 
  • The oncology care model and the future of alternative payment models: A gynecologic oncology perspective. 
  • Third CECOG consensus on the systemic treatment of non-small-cell lung cancer. 
  • Thrombosis and cancer: emerging data for the practicing oncologist. 
  • Time for a neoadjuvant chemotherapy strategy in prostate cancer? 
  • Time to add screening for financial hardship as a quality measure? 
  • Time-Driven Activity-Based Costing in Oncology: A Step in the Right Direction. 
  • Timing of surgery and radiotherapy in the management of metastatic spine disease: a systematic review. 
  • Tomorrow's cancer treatments today: the first 50 years of the Cancer and Leukemia Group B. 
  • Training and practice activities of hematology and medical oncology diplomates. 
  • Transforming epidemiology for 21st century medicine and public health. 
  • Trends in hospital-physician integration in medical oncology. 
  • Under-representation of women in high-impact published clinical cancer research. 
  • Understanding Effective Delivery of Patient and Family Education in Pediatric Oncology_{A Systematic Review From the Children's Oncology Group [Formula: see text]} . 
  • Understanding cognition in older patients with cancer. 
  • Unique challenges for glioblastoma immunotherapy-discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank. 
  • Urological Oncology: Prostate Cancer. 
  • Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). 
  • Use of erythropoietin in cancer patients: assessment of oncologists' practice patterns in the United States and other countries. 
  • Use of patient registries and administrative datasets for the study of pediatric cancer. 
  • Use of research biopsies in clinical trials: are risks and benefits adequately discussed? 
  • Using Patient Reported Outcomes in Oncology Clinical Practice. 
  • Using a geriatric oncology assessment to link with services (GOAL). 
  • Using health communication best practices to develop a web-based provider-patient communication aid: the CONNECT study. 
  • VA Cancer Research: A Legacy and A Future. 
  • Venous thromboembolic disease. Clinical practice guidelines in oncology. 
  • Venous thromboembolism prophylaxis and treatment in cancer: a consensus statement of major guidelines panels and call to action. 
  • Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2013. 
  • What is New in Neuro-oncology? 
  • When and why should patients with hematologic malignancies see a palliative care specialist? 
  • When worlds collide: Challenges to implementing communication research in community oncology practices. 
  • Why Are We Failing to Do What Works? Musings on Outpatient Palliative Care Integration in Cancer Care. 
  • Why Burnout Is So Hard to Fix. 
  • Why do patients with cancer visit emergency departments? Results of a 2008 population study in North Carolina. 
  • Wide variation in payments for Medicare beneficiary oncology services suggests room for practice-level improvement. 
  • Work related stress among gynecologic oncologists. 
• 

  Keywords of People

  • Bansal, Rani, Assistant Professor of Medicine, Medicine, Medical Oncology
  • Berchuck, Andrew, James M. Ingram Distinguished Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology
  • Grambow, Steven C., Associate Professor of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics
  • Olsen, Maren Karine, Professor of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics
  • Strand de Oliveira, Justine, Professor Emeritus in Family Medicine and Community Health, Family Medicine and Community Health, Physician Assistant Program
  • Thomas, Melanie Byrne, Associate Professor of Medicine, Medicine, Medical Oncology
  • Zafar, Syed Yousuf, Adjunct Professor in the Department of Medicine, Duke Science & Society